The announcement is a statewide public-health development. The new dashboard is intended to provide continuing information about cyclosporiasis cases in North Carolina, giving residents and public-health officials a public place to monitor information released by the state.

The accessible state press-release record confirms the additional cases and the dashboard launch. It does not provide an updated number of cases, identify a suspected source of the illnesses or say whether the cases are connected to a single source.

What changed on July 28

NCDHHS added a public tracking tool as it reported additional cases of cyclosporiasis. The state’s press-release listing describes the dashboard as new and identifies the development as a North Carolina statewide public-health response.

The dashboard’s stated role is to provide ongoing information about cases in the state. That makes the dashboard the next identified public source for information as the state releases it.

The available record does not describe the dashboard’s contents, including whether it displays case counts, case locations, dates or other measures. It also does not provide instructions about how often information will be updated.

What the available record does not establish

No numerical total is reported here because the accessible press-release listing does not show an updated case count. Reporting a total without the underlying release or the dashboard itself would go beyond the available official record.

Likewise, the record does not identify a food, product, business or other suspected origin for the cases. It does not say that investigators have linked all identified cases to one source, and it does not establish an outbreak origin.

The available information also does not establish whether transmission was ongoing as of Aug. 3. The announcement confirms that additional cases had been identified by July 28; it does not, on the record available here, state whether new cases continued to be identified after that date.

Why the dashboard matters

The state’s announcement creates a public tracking tool around a gastrointestinal illness outbreak. For residents, the dashboard is intended to offer continuing statewide case information rather than leaving the July 28 announcement as the only identified public update.

For public-health monitoring, the state’s action establishes a designated public dashboard alongside the announcement of additional cases. But the accessible listing does not provide enough detail to determine the size of the reported case increase, the geographic distribution of cases or the status of any investigation.

Those limits are important. The announcement supports reporting that the state has identified additional cases and has created a dashboard; it does not support conclusions about the scale of the outbreak, its cause or whether it is expanding.

What comes next

The next known step is continuing public information through the case dashboard announced by NCDHHS. The available state record does not specify a date for a further briefing, an investigation deadline or when an updated case count might be released.

Until the state provides those details, the confirmed development remains the July 28 identification of additional North Carolina cases and the launch of the public dashboard intended to track ongoing information about them.

That testing emphasis matters because AFM can be clinically and radiographically indistinguishable from paralytic poliomyelitis. “Lower AFM incidence” does not mean polio can be ignored during AFM-like evaluations.

What CDC found in its AFM surveillance update

CDC reports 172 confirmed AFM cases across the surveillance period, including:

• 2020: 34
• 2021: 29
• 2022: 48
• 2023: 19
• 2024: 25
• 2025: 17

CDC also contrasts this with earlier U.S. peaks—linked to enterovirus circulation in 2014, 2016, and 2018—when AFM counts were higher at 120–238 cases per year. In plain terms: the 2020–2025 period was “lower” than those peak years.

Why “low AFM” still requires polio testing

AFM is part of a broader clinical syndrome called acute flaccid paralysis. In CDC’s report, the key public-health point is straightforward: if symptoms and imaging suggest AFM, the workup still has to rule out paralytic polio.

In the 2020–2025 period, CDC reports that:

• Approximately one half of AFM patients had stool specimens tested for poliovirus.
• 75%–100% of AFM patients had received at least 3 polio vaccine doses.
• In 2022, one poliomyelitis case in New York was identified through poliovirus testing of stool specimens collected during AFM surveillance.

CDC’s takeaway for clinicians and health departments is that AFM-like cases should trigger stool collection and poliovirus testing to avoid diagnostic misses.

What clinicians and public health agencies should do

CDC emphasizes a practical workflow:

• Ensure stool samples are collected from people with an acute onset of flaccid weakness or paralysis when AFM is suspected.
• Report cases to local health departments so AFM and polio surveillance can be completed.

In CDC’s surveillance framework, if a stool specimen tested for poliovirus is positive, that patient would be classified as a confirmed paralytic poliomyelitis case rather than AFM—underscoring why the testing step is essential.

What families should take away

If someone—especially a child—develops sudden weakness or flaccid paralysis, the message is not to wait. Seek urgent medical evaluation, because part of the medical evaluation for AFM-like presentations may include stool testing to rule out serious causes such as poliovirus.

CDC also notes that staying up to date with polio vaccination remains important for long-term protection against paralytic polio.

What to watch next

CDC will continue AFM surveillance updates. For clinicians and families, the steady “watch next” takeaway is the same: if AFM-like symptoms appear, health systems should not skip stool collection and poliovirus testing just because confirmed AFM counts were lower in 2020–2025.

Sources

• CDC MMWR (July 9, 2026): Acute Flaccid Myelitis Surveillance — United States, January 2020–December 2025